US Patent

US11071742 — Compositions for improving cell viability and methods of use thereof

Formulation · Assigned to Amylyx Pharmaceuticals Inc · Expires 2033-12-24 · 8y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects compositions and methods for improving cell viability, particularly neural cell viability, using a combination of tauroursodeoxycholic acid and phenylbutyric acid.

USPTO Abstract

This invention relates to methods and compositions for use improving cell viability, particularly neural cell viability, and more particularly to methods and compositions for use improving cell viability by reducing reactive oxygen metabolite-mediated oxidative damage in a cell, regulating redox homeostasis in a cell, or reducing mitochondrial dysfunction in a cell. The invention further relates to the administration of the bile acid tauroursodeoxycholic acid (TUDCA) in combination with phenylbutyric Acid (PBA) to improve cell viability, and treat at least one symptom associated with, prevent the time of onset of, or slow the development of a disease related to oxidative stress.

Drugs covered by this patent

Patent Metadata

Patent number
US11071742
Jurisdiction
US
Classification
Formulation
Expires
2033-12-24
Drug substance claim
No
Drug product claim
Yes
Assignee
Amylyx Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.